Patent · US Active

Amlodipine formulations

US10695329B2 · kind B2 · utility

13Cited by
23References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 6, 2017
Grant dateJun 30, 2020
Priority date—
Expiry dateOct 16, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are stable amlodipine oral liquid formulations. Also provided herein are methods of using amlodipine oral liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.